Our people-centric design innovation is recognised on the global awards stage
An AstraZeneca concept collaboration is one of three projects by deep tech consultants at Cambridge Consultants to receive prestigious iF DESIGN AWARDS
Generative biology breakthrough from Capgemini – PharmaTimes
Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes
Capgemini reveals gen AI-driven breakthrough to accelerate the bioeconomy
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development.
Omniscia: Deep tech superhuman surgery in real time
Deep learning and AI enhanced imaging for superhuman surgery has propelled Omniscia, which now sets the standard for real-time video super resolution.
What is deep tech? A strategy to create value from an enduring, defensible competitive advantage
What is deep tech? When discussing deep tech meaning, deep tech consultants Cambridge Consultants define it as a strategy for value and commercial advantage.
A promising breakthrough in the fight against glaucoma blindness
What is glaucoma? It’s a condition that represents the leading cause of irreversible blindness worldwide. A team of CC scientists and engineers have made a promising breakthrough for the monitoring of interocular pressure (IOP), a major contributor to glaucoma.